Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Imidazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole SCHEMBL15510869 | 1.00 | ALDH1A1 (0.65) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL10782275 | 0.97 | — | — | |
| Imidazole SCHEMBL10783118 | 0.97 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL10783121 | 0.97 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL15510965 | 0.95 | ALDH1A1 (0.65) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL15510964 | 0.95 | ALDH1A1 (0.65) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL15571339 | 0.93 | ALDH1A1 (0.62) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL15572003 | 0.93 | ALDH1A1 (0.62) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL15511003 | 0.89 | ALDH1A1 (0.56) | ALDH1A1FKBP5 | |
| Sulfuric Acid SCHEMBL28436802 | 0.89 | ALDH1A1 (0.56) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150202607-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | Midori Renewables, Inc. (US) | 2015-07-23 | — | — | US | claimed |
| EP-2888044-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | Midori Renewables, Inc. (US) | 2015-07-01 | — | — | EP | claimed |
| WO-2014031956-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | Midori Renewables, Inc. (US) | 2014-02-27 | — | — | WO | claimed |
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. | 2023-08-17 | — | — | US | disclosed |
| EP-4209130-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | DSM Nutritional Products, LLC (US) | 2023-07-12 | — | — | EP | disclosed |
| EP-4205553-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | DSM Nutritional Products, LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | DSM NUTRITIONAL PRODUCTS, LLC | 2022-12-29 | — | — | US | disclosed |
| US-20220400728-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-12-22 | — | — | US | disclosed |
| US-20210352945-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF | HERCULES CAPITAL, INC. | 2021-11-18 | — | — | US | disclosed |
| WO-2016122884-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| WO-2016122885-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| WO-2016122940-A1 | METHODS OF PRODUCING ANHYDROSUGAR ALCOHOLS | MIDORI USA, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| WO-2016122887-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| US-9238845-B2 | Methods of producing sugars from biomass feedstocks | MIDORI USA, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| US-20160007642-A1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | MIDORI USA, INC. (US) | 2016-01-14 | — | — | US | disclosed |
| WO-2016007778-A1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | MIDORI USA, INC. (US) | 2016-01-14 | — | — | WO | disclosed |
| US-20150202607-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | Midori Renewables, Inc. (US) | 2015-07-23 | — | — | US | disclosed |
| US-20140060522-A1 | METHODS OF PRODUCING SUGARS FROM BIOMASS FEEDSTOCKS | HERCULES CAPITAL, INC. | 2014-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | FUT5, FUT6, OSTC | ALDH1A1 3518/4885FKBP5 2947/4885 |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | OSTC, FUT5, FUT6 | ALDH1A1 2641/4885FKBP5 3757/4885 |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | FUT5, FUT6, OSTC | ALDH1A1 3518/4885FKBP5 2947/4885 |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | FUT6, FUT5, PIGS | ALDH1A1 2993/4885FKBP5 1960/4885 |
| US-20210352945-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF | OSTC, FUT5, FUT6 | ALDH1A1 4478/4885FKBP5 3284/4885 |
| US-20150202607-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | MGAM, CEL, SI | ALDH1A1 2291/4885FKBP5 2396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.